Upgrades, downgrades, and outlook changes from major analysts.
Coverage of analyst actions including upgrades, downgrades, initiations, and price-target changes. This category tracks how institutional research influences market perception, momentum shifts, and short-term price behavior.
1,429 total articles
TD Cowen maintained its Buy rating and $95 price target for Customers Bancorp (CUBI) after an 8% decline in the stock following the bank's fourth-quarter 2025 results. The firm characterizes the pullback as overdone, highlighting an EPS beat, robust revenue growth and progress on deposit remixing, while noting the bank's 2026 guidance appears cauti…
Bernstein has reaffirmed an Underperform rating and a $85 price target on Deckers Outdoor ahead of the retailer's fiscal third-quarter earnings report scheduled for January 29. The firm points to slowing growth and weakening brand momentum for Hoka and Ugg, and its forecasts assume margin pressure not fully captured in consensus estimates. Other br…
Bernstein has reaffirmed an Outperform rating and an $84.00 price target on Hershey Co., underscoring cocoa input cost uncertainty as the primary variable for near-term profitability. The firm models higher cocoa prices through 2025 and, after accounting for volume losses tied to aggressive price increases in 2025, arrives at more conservative 2026…
Bernstein SocGen Group retained an Outperform rating and an $84.00 price target for Mondelez International (MDLZ), implying roughly 43% upside from the current share price of $58.66. The firm’s note examines the company’s cocoa cost exposure relative to peers, the role of cocoa butter inflation in 2024, and management’s likely approach to any futur…
Bernstein reduced its price target for Grab Holdings Inc. to $5.80 from $6.60 while retaining an Outperform rating, reflecting expected margin pressure as the Southeast Asian technology group invests to broaden its total addressable market. The firm trimmed calendar year 2025-2026 net income forecasts by 2-5.6% to account for the near-term effect o…
Bernstein SocGen Group reaffirmed an Outperform rating and a $100 price target on Starbucks (SBUX) ahead of the company’s investor day, forecasting a sequential acceleration to 3.3% same-store sales growth in fiscal first quarter 2026 versus a consensus 1.8% estimate. While the firm views the company’s strategy as sound and early indicators as supp…
Stifel raised its SLB price target to $56 from $52 and kept a Buy rating after the oilfield services company reported stronger-than-expected fourth-quarter 2025 results. Management’s comment that "the worst is likely behind us" aligns with Stifel’s view that the downward estimate revision cycle is ending, with growth anticipated in the second half …
Piper Sandler raised its price target on 1st Source (SRCE) to $83 from $80 and kept an Overweight rating, citing a better-than-expected fourth quarter driven by stronger net interest income and margin expansion. The firm increased EPS forecasts for 2026 and 2027 and highlighted solid balance sheet metrics, while other banks also adjusted targets fo…
Bernstein SocGen Group has reiterated an Outperform rating on ASML and set a $1,642 price objective ahead of the company's earnings scheduled for Wednesday, January 28. The firm points to import data and elevated expectations for bookings as evidence the quarter may beat consensus revenue estimates, while several other brokerages have recently adju…
Jones Trading upgraded Orion Office REIT Inc (ONL) from Hold to Buy and established a $3.00 price target following the REIT's initiation of a strategic options review and a cooperation agreement with its largest shareholder, The Kawa Fund Limited. The analyst house estimates a fourth-quarter 2025 NAV of $5.04 per share and cites near-term balance s…
Shares of InMode Ltd. climbed Monday after reports that the company is in advanced negotiations to be acquired by a foreign investment fund for roughly $1.1 billion. The reported price would represent a notable premium to the company's current market value and, if completed, would take the firm private and lead to delisting.
Piper Sandler has reiterated an Overweight rating on Nektar Therapeutics (NKTR) with a $105 price target, citing strong induction data for REZPEG and ample liquidity to support clinical programs. The firm flagged durability of response and regulatory endpoints as primary considerations ahead of maintenance topline results anticipated in the first q…
Piper Sandler maintained an Overweight rating and a $16.00 price target on Ford, citing the potential for substantial earnings improvement in 2026 should the automaker reduce warranty-related costs. The firm highlights up to $2.8 billion of incremental EBIT versus 2025 and a $0.54 per-share EPS uplift as a scenario if quality trends meaningfully im…
Piper Sandler increased its price target on Independent Bank (IBCP) to $39 from $36 and kept a Neutral rating, citing a revised net interest margin outlook for 2026 and modest loan growth. The firm raised 2026 and 2027 EPS estimates and highlighted profitability metrics, while InvestingPro data flags a relatively high P/E and notes the company has …
Piper Sandler raised its price objective on Amerant Bancorp Inc to $25 from $22 and reiterated an Overweight rating, citing the bank's focus on stabilizing operations after completing a credit review and implementing efficiency measures. The firm noted a mixed Q4 2025 performance with revenue above expectations but a sizable EPS miss, and highlight…
Truist Securities reaffirmed its Buy rating and $99 price target on Revolution (NASDAQ: RVMD) following reports that acquisition talks with Merck stalled over price. The brokerage interprets the reported $30 billion figure as a validation of Revolution’s value, highlights management confidence in the clinical program, and says the company is well-f…
Piper Sandler increased its price objective on Bank First National Corp. (NASDAQ:BFC) to $150 from $142 while maintaining a Neutral rating. The new target implies roughly 8% upside from the current share price and is underpinned by solid quarterly results, revised earnings forecasts for 2026 and 2027, and a favorable profitability outlook. The bank…
Scotiabank upgraded Eldorado Gold Corp (EGO) from Sector Perform to Sector Outperform and raised its price target to $59 from $33, citing the imminent start of production at the Skouries mine in the first quarter of 2026. The firm expects the project will pivot Eldorado from negative to positive free cash flow and drive a re-rating of the stock. Se…
Scotiabank downgraded Royal Gold from Sector Outperform to Sector Perform, attributing the move solely to recent share price gains and a reduced expected return to its $335.00 target. The stock is trading at $29.83, close to its 52-week high, while technical indicators point to overbought conditions. Separately, Scotiabank upgraded Eldorado Gold an…
Stephens increased its price target for Atlantic Union Bankshares (AUB) to $45 from $43 and kept an Overweight rating after the regional bank reported quarterly results that topped consensus on several fronts. The company delivered higher-than-expected pre-provision net revenue, expanding net interest margin and solid loan growth, while dividend co…
JPMorgan has reaffirmed a Neutral rating and a $100 price target on Roblox Corp. after the platform experienced a marked decline in weekend engagement, with peak concurrent users falling to 23 million. Weekday activity appeared steadier, while year-over-year engagement eased to 71% for January-to-date. Analysts are split on the stock, with price ta…
BofA Securities reduced its price target for Public Service Enterprise Group Inc. (PEG) to $84.00 from $95.00 but kept a Buy rating, citing regulatory pressure that prompted the removal of an electric premium and a reduction of the gas premium to 10%. The bank slightly lowered its full-year 2025 EPS forecast to $4.05 and expects fourth-quarter 2025…
Bausch Health Companies announced that its global Phase 3 RED-C program evaluating amorphous-rifaximin solid soluble dispersion (SSD) for primary prevention of hepatic encephalopathy did not meet the trial's primary endpoint. The result marks a material reversal for a program aimed at a large liver cirrhosis population and has contributed to recent…
Stephens increased its price target on South State (NYSE: SSB) to $120 from $110 while keeping an Overweight rating, highlighting a core pre-provision net revenue (PPNR) beat, solid net interest income and fee momentum. The bank reported strong fourth-quarter 2025 results that topped estimates, and Raymond James separately raised its target to $120…
Piper Sandler raised its price objective for AMD to $300 from $280 and kept an Overweight rating, projecting revenue upside and modest EPS beats in upcoming quarters. Other firms including KeyBanc and Bernstein have also updated views, while corporate developments and supplier expectations underscore the market's attention on AMD's server and AI ef…
